Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New non-ionic contrast: effects on the cardiovascular system

J Y Pagny1, J C Gaux

  • 1Hôpital Broussais, Paris, France.

European Journal of Radiology
|November 1, 1996
PubMed
Summary

New nonionic contrast media like Iomeprol offer improved cardiovascular safety. Clinical trials show Iomeprol is well-tolerated in cardioangiography due to its low osmolality and toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Why Coronary CTA will affect the diagnosis and management of stable coronary artery disease?].

Journal de radiologie·2009
Same author

[Critical limb ischaemia: endovascular treatment in diabetic patients?].

Archives des maladies du coeur et des vaisseaux·2005
Same author

[Lower limb arterial disease: Doppler sonography follow-up after revascularization].

Journal de radiologie·2003
Same author

[Glycoprotein IIb/IIIa inhibitors in unstable angina].

Annales de cardiologie et d'angeiologie·2003
Same author

Percutaneous transluminal angioplasty of the anomalous circumflex artery.

Journal of interventional cardiology·2002
Same author

[Value of helical CT in Takayasu arteritis].

Journal de radiologie·2001

Area of Science:

  • Cardiovascular Medicine
  • Radiology
  • Pharmacology

Background:

  • Contrast media can induce hemodynamic and electrophysiologic effects on the cardiovascular system.
  • These effects are influenced by the physico-chemical properties of the contrast agents.
  • Low osmolar nonionic contrast media exhibit fewer adverse effects compared to ionic agents, but further improvements are desirable.

Purpose of the Study:

  • To evaluate the safety and tolerability of Iomeprol, a novel nonionic contrast medium, in cardioangiography.
  • To assess the cardiovascular effects of Iomeprol in clinical settings.

Main Methods:

  • Clinical trials were conducted to assess Iomeprol's performance in cardioangiography.
  • Evaluation focused on hemodynamic and electrophysiologic parameters, as well as overall tolerability.

Main Results:

  • Iomeprol demonstrated low osmolality, low toxicity, and very low viscosity.
  • Clinical trials indicated that Iomeprol was safe and well-tolerated during cardioangiography procedures.

Conclusions:

  • Iomeprol represents a new generation of nonionic contrast media with favorable physico-chemical properties.
  • Its safety and tolerability profile make it a suitable option for cardioangiography.

Related Experiment Videos